CMS approves Medicaid waivers to treat substance use disorders

The Centers for Medicare & Medicaid Services last week Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders. Both states will receive Medicaid matching funds for treatment in facilities that meet the definition of an institution for mental diseases, which include hospitals and other residential treatment facilities with more than 16 beds that are primarily engaged in diagnosis, treatment or care of persons with mental diseases. CMS outlined additional waiver opportunities last November for states to treat SUDs and mental illness.
Related News Articles
Headline
The latest video in the AHA鈥檚 series 鈥淢edicaid: Real Lives, Real Care鈥 features Jennifer Clowers, regional chief financial officer of Our Lady of the Lake鈥
Headline
The AHA June 10 released a new video in its series, 鈥淢edicaid: Real Lives, Real Care,鈥 that features Missouri Hospital Association President and CEO Jon鈥
Headline
The White House June 6 issued a memorandum directing the Secretary of the Department of Health and Human Services 鈥渢o take appropriate action to eliminate鈥
Headline
The House June 4 passed the AHA-supported SUPPORT Act (H.R. 2483) by a 366-57 vote. The legislation reauthorizes key prevention, treatment and recovery鈥
Headline
A Congressional Budget Office report released June 4 found that enactment of the fiscal year 2025 budget reconciliation bill, the One Big Beautiful Bill Act (H鈥
Headline
The AHA June 3 launched the first in a new video series, 鈥淢edicaid: Real Lives, Real Care,鈥 highlighting the importance of Medicaid and why proposed cuts鈥